Goe et al. v. U.S. Department of Health and Human Services, et al.

On October 1, 2026, GLAD Law, the National Center for LGBTQ Rights, and the ACLU of New Hampshire filed a lawsuit asking a federal court to stop the Trump administration from enforcing a rule against our clients that will take medical care away from transgender youth in low-income families.

The rule was issued in August 2026 by the Centers for Medicare & Medicaid Services. Effective October 13, 2026, it cuts off federal Medicaid and CHIP funding for medications and other treatment for gender dysphoria for young people. The ban applies even when a patient’s own doctor has determined the care is medically necessary.

We are filing on behalf of four New Hampshire teenagers and their families. These are kids who are already in treatment. Their families made these medical decisions with their doctors, based on careful assessment of their children’s medical needs.

But, on October 13, the Trump administration plans to pull the funding for these kids’ health care mid-treatment, with no plan for what happens to them.  Stopping treatment abruptly, against the judgment of these children’s own parents and doctors, will hurt these kids.

Not only is this rule cruel, but it is also illegal. Congress created the Medicaid program 50 years ago, and the regulations governing Medicaid say that it can’t deny a covered service because of a patient’s diagnosis. But that’s exactly what this rule does.

More than 90% of the public comments submitted about this rule opposed it. The law says the government must engage with this evidence, not wave it away, before implementing any new regulation. But the Trump administration ignored both the people’s voice and the law, and forged ahead anyway.